![]() |
市场调查报告书
商品编码
1818029
2032年復健机器人市场预测:按产品类型、应用、最终用户和地区进行的全球分析Rehabilitation Robotics Market Forecasts to 2032 - Global Analysis By Product Type (Therapeutic Robots, Exoskeletons, Assistive Robots, and Other Product Types), Application, End User and By Geography |
根据 Stratistics MRC 的数据,全球康復机器人市场预计在 2025 年达到 5.0161 亿美元,到 2032 年将达到 15.236 亿美元,预测期内的复合年增长率为 17.2%。
復健机器人技术是指专注于设计、开发和实施机器人设备以协助患者在受伤、患病或神经病变后恢復身体能力的机器人技术领域。这些系统旨在透过提供一致、精确和重复的运动来支持运动学习和功能恢復,从而提高治疗效果。復健机器人可用于上下肢训练、步态辅助和认知运动康復,通常整合感测器和软体,以根据患者的特定需求调整治疗方案。作为传统物理治疗的补充,復健机器人可以改善患者的治疗效果,减轻治疗师的工作量,并提高患者在日常活动中的独立性。
神经系统疾病增加
人工智慧设备正在提高治疗的精准度和个人化。医疗保健提供者正在使用机器人技术来改善治疗效果并减轻治疗师的工作量。长期残疾管理正在推动扩充性方案的需求。与临床工作流程的整合正在扩大其在医疗保健领域的应用。这些趋势正在强化机器人技术作为神经復健核心工具的地位。
对某些患者疗效有限
缺乏标准化通讯协定和临床结果参差不齐影响了医护人员的信心。患者参与度和认知能力影响治疗成功率。混合模式和个体化评估对于提高疗效至关重要。长期数据有限,导致检验和报销延迟。这些因素影响了不同临床环境下的采用。
家庭医疗保健的采用率不断提高
紧凑直观的设备可支援远端医疗和看护者的参与。与远端医疗的整合正在改善可近性和监控。对减少医院依赖的经济实惠的解决方案的需求日益增长。模组化设计使居家慢性病护理支援成为可能。这些发展正在推动非临床应用的成长。
发展中地区的可及性
设备昂贵和缺乏熟练人员限制了部署。医疗保健和医学的碎片化降低了经济可行性。文化和文化素养的挑战影响了病人的参与度。改善医疗服务可近性和培训需要各方共同努力。这些动态正在减缓全球市场的扩张。
新冠疫情对復健机器人市场产生了重大影响。医疗服务和选择性手术的中断减少了患者获得机器人復健解决方案的机会。供应链中断影响了机器人设备的製造和交付。然而,这场危机加速了人们对远距和居家復健技术的兴趣,并推动了远距復健和自动化治疗系统的创新。医疗保健提供者越来越多地寻求能够最大程度减少直接接触并确保患者护理连续性的解决方案,这凸显了康復机器人领域的挑战和新机会。
预计外骨骼细分市场将成为预测期内最大的细分市场
外骨骼领域预计将在预测期内占据最大的市场份额,这得益于其在运动復健和步态训练中的应用。其应用范围涵盖中风、脊髓损伤和整形外科復健。材料和感测器的进步正在提升其性能。它们在临床和研究环境中的应用日益广泛。需求涵盖被动和主动系统。由于其治疗用途的多样性,预计该领域将继续保持领先地位。
预计儿科復健领域在预测期内将以最高的复合年增长率成长
由于对早期疗育和发展支持的日益重视,儿科復健领域预计将在预测期内实现最高成长率。机器人工具正针对脑性麻痹和肌肉萎缩症病症进行客製化。游戏化介面和自适应回馈正在提升参与度。学校和诊所正在投资儿童友善系统。研究和资金正在支持创新。随着机器人技术在儿科医疗保健中的重要性日益凸显,该领域必将迎来快速成长。
在预测期内,由于美国和加拿大拥有先进的医疗基础设施和最尖端科技的广泛应用,北美预计将占据最大的市场份额。医院和復健中心越来越多地采用治疗机器人、外骨骼和上下肢辅助器具,以改善患者的復健效果。肌肉骨骼疾病、中风和神经系统疾病的盛行率不断上升,推动了需求成长。政府措施和保险覆盖范围支持机器人辅助治疗。科技新兴企业与成熟医疗设备公司之间的合作,重点关注精准、安全和个人化的復健解决方案,将进一步促进市场成长。
由于老年人口不断增长和慢性病盛行率不断上升,预计亚太地区将在预测期内实现最高的复合年增长率。市场成长得益于政府医疗现代化计划和医疗技术投资。外骨骼和穿戴式机器人设备在医院和家庭护理机构中越来越受欢迎。本地公司正在创新经济高效的解决方案,以应对可负担性挑战。宣传宣传活动和与国际公司的合作正在推动相关技术的普及,而技术进步则专注于提高患者在復健治疗中的活动能力、灵活性和参与度。
According to Stratistics MRC, the Global Rehabilitation Robotics Market is accounted for $501.61 million in 2025 and is expected to reach $1523.6 million by 2032 growing at a CAGR of 17.2% during the forecast period. Rehabilitation robotics refers to the branch of robotics focused on designing, developing, and implementing robotic devices to assist individuals in recovering physical abilities after injury, illness, or neurological disorders. These systems aim to enhance the effectiveness of therapy by providing consistent, precise, and repetitive movements that support motor learning and functional recovery. Rehabilitation robots can be used for upper or lower limb training, gait assistance, and cognitive-motor rehabilitation, often integrating sensors and software to adapt therapy to the patient's specific needs. By complementing traditional physiotherapy, rehabilitation robotics improves patient outcomes, reduces therapist workload, and promotes independence in daily activities.
Rising incidence of neurological disorders
AI-enabled devices are improving therapy precision and personalization. Providers are using robotics to enhance outcomes and reduce therapist burden. Long-term disability management is increasing demand for scalable solutions. Integration with clinical workflows is expanding use across care settings. These trends are reinforcing robotics as a core tool in neurorehabilitation.
Limited effectiveness for certain patients
Lack of standardized protocols and mixed clinical results are affecting provider confidence. Patient engagement and cognitive capacity influence therapy success. Hybrid models and tailored assessments are needed to improve efficacy. Limited long-term data is slowing validation and reimbursement. These factors are impacting adoption in diverse clinical environments.
Increased adoption in home healthcare
Compact and intuitive devices support remote therapy and caregiver involvement. Telehealth integration is improving accessibility and monitoring. Demand is rising for affordable solutions that reduce hospital dependency. Modular designs are enabling chronic care support at home. These developments are driving growth in non-clinical applications.
Accessibility in developing regions
Equipment affordability and skilled personnel shortages limit deployment. Insurance and healthcare fragmentation reduces financial feasibility. Cultural and literacy challenges affect patient engagement. Collaborative efforts are needed to improve access and training. These dynamics are slowing global market expansion.
The COVID-19 pandemic significantly impacted the rehabilitation robotics market. Disruptions in healthcare services and elective procedures led to reduced patient access to robotic rehabilitation solutions. Supply chain interruptions affected the manufacturing and delivery of robotic devices. However, the crisis also accelerated interest in remote and home-based rehabilitation technologies, driving innovation in tele-rehabilitation and automated therapy systems. Healthcare providers increasingly sought solutions that minimize direct contact while ensuring continuous patient care, highlighting both challenges and emerging opportunities in the rehabilitation robotics sector.
The exoskeletons segment is expected to be the largest during the forecast period
The exoskeletons segment is expected to account for the largest market share during the forecast period due to their use in mobility restoration and gait training. Applications span stroke, spinal injury, and orthopedic recovery. Advances in materials and sensors are improving performance. Adoption is growing across clinical and research settings. Demand spans passive and active systems. This segment will continue to lead due to its therapeutic versatility.
The pediatric rehabilitation segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the pediatric rehabilitation segment is predicted to witness the highest growth rate due to emphasis on early intervention and developmental support. Robotic tools are being tailored for conditions like cerebral palsy and muscular dystrophy. Gamified interfaces and adaptive feedback are enhancing engagement. Schools and clinics are investing in child-friendly systems. Research and funding are supporting innovation. This segment is set for rapid growth as robotics becomes central to pediatric care.
During the forecast period, the North America region is expected to hold the largest market share by advanced healthcare infrastructure and high adoption of cutting-edge technologies in the United States and Canada. Hospitals and rehabilitation centers increasingly implement upper and lower limb therapy robots, exoskeletons, and assistive devices to improve patient outcomes. Rising prevalence of musculoskeletal disorders, stroke, and neurological conditions fuels demand. Government initiatives and insurance coverage support robotic-assisted therapies. Collaborations among tech startups and established medical device companies further strengthen market growth, emphasizing precision, safety, and personalized rehabilitation solutions.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR due to increasing geriatric populations and rising incidence of chronic diseases. Market growth is supported by government healthcare modernization programs and investments in medical technology. Exoskeletons and wearable robotic devices are gaining traction in hospitals and home-care settings. Local companies are innovating cost-effective solutions to meet the affordability challenge. Awareness campaigns and collaborations with international players are expanding adoption, while technological advancements focus on enhancing mobility, dexterity, and patient engagement in rehabilitation therapies.
Key players in the market
Some of the key players in Rehabilitation Robotics Market include Hocoma AG, ReWalk Robotics Ltd., Ekso Bionics Holdings Inc., Cyberdyne Inc., Bionik Laboratories Corp., Fourier Intelligence, Kinova Inc., Tyromotion GmbH, Rex Bionics Ltd., AlterG Inc., Wandercraft, Myomo Inc., Able Human Motion, Gogoa Mobility Robots and Bioness Inc.
In July 2025, Ekso Bionics announced a strategic distribution partnership with Bionic Prosthetics & Orthotics Group, marking its first channel for the Ekso Indego Personal device. This collaboration expands access to wearable exoskeletons across orthotics networks, targeting mobility-impaired individuals in outpatient and home settings.
In November 2023, ReWalk Robotics partnered with Israel's Human Robot Interaction Consortium under the MAGNET program to develop AI-enabled exoskeletons. The collaboration integrates advanced sensors and autonomous decision-making, allowing the device to adapt to terrain and reduce cognitive load for users.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.